Dissecting the function of GORAB, the protein mutated in Geroderma osteodysplastica

剖析 GORAB 的功能,GORAB 是骨发育不良中突变的蛋白质

基本信息

  • 批准号:
    MR/N000366/1
  • 负责人:
  • 金额:
    $ 51.51万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2015
  • 资助国家:
    英国
  • 起止时间:
    2015 至 无数据
  • 项目状态:
    已结题

项目摘要

Skin, bone, cartilage and connective tissues in our body are clearly important, providing a range of functions that are essential for life. The components of all of these tissues are made inside special types of cells in our body, which then release, or secrete, them outside the cell, upon which the individual components assemble to form complex networks that ultimately generate the physical structure of the particular tissue. The secreted components are typically large proteins that undergo extensive modifications prior to and after their secretion from the cell. The secreted proteins are synthesized in a particular compartment inside the cell called the endoplasmic reticulum, where many undergo extensive modification, commonly involving the addition of linked chains of sugars in a process termed glycosylation. Proteins are then transported in small spherical packets to another compartment called the Golgi apparatus, where further glycosylation and processing of the added sugar chains occurs. The modified proteins are then packaged at the Golgi apparatus into different vesicles for delivery to the cell surface and release from the cell. Many human diseases affect the formation or maintenance of the skin and bones, and moreover, it is well known that both tissues degenerate as people get older. A rare genetic disorder called Geroderma osteodysplastica causes loose, wrinkly skin and osteoporosis, symptoms similar to those seen in ageing. The cause of GO is mutation of a gene that encodes for a Golgi apparatus protein called GORAB. The function of GORAB is not known, and consequently we do not understand how the symptoms of GO are brought about. We have obtained preliminary evidence that GORAB is important for vesicle transport at the Golgi complex and for the correct processing of sugar chains on cargo proteins transiting through this compartment. Hence, we propose that GO is caused by defective modification of proteins that make up the skin and bone, leading to the pathological effects that are observed in these tissues. The work described here aims to determine the precise function of GORAB in Golgi vesicle transport, and then to determine how the loss of GORAB affects modification of secreted proteins, focusing on those that make up the skin. The work will not only be important for determining the mechanisms of GO, but have more widespread significance for our understanding of cargo modification more generally, which is of fundamental importance to all cells. Moreover, the results will inform us of how the skin is assembled, and how the skin changes both in disease but also likely during the normal ageing process. Finally, the work also has relevance to our understanding of processes such as tissue regeneration and wound repair.
我们体内的皮肤,骨骼,软骨和结缔组织显然很重要,提供了一系列对生命必不可少的功能。所有这些组织的成分是在我们体内特殊类型的细胞内部制成的,然后将它们释放或分泌,将它们在细胞之外释放或分泌,在这些细胞中,各个组件在其上组装以形成复杂的网络,以最终产生特定组织的物理结构。分泌的成分通常是大型蛋白质,它们在分泌细胞之前和之后进行了广泛的修饰。分泌的蛋白质是在称为内质网的细胞内部特定隔室中合成的,其中许多经历了广泛的修饰,通常涉及在称为糖基化的过程中添加糖的连锁链。然后,将蛋白质在小球包中运输到另一个称为高尔基体设备的隔室,在此过程中,发生了进一步的糖基化和添加的糖链的加工。然后将修饰的蛋白质在高尔基体中包装到不同的囊泡中,以递送至细胞表面并从细胞中释放。许多人类疾病会影响皮肤和骨骼的形成或维持,而且众所周知,随着人们的年龄增长,两者都会退化。一种称为头皮骨质塑料的罕见遗传疾病会导致皮肤松动,骨质疏松症,症状与衰老中的症状相似。 GO的原因是一个基因的突变,该基因编码称为Gorab的高尔基体蛋白。 Gorab的功能尚不清楚,因此我们不了解GO的症状是如何带来的。我们已经获得了初步证据,表明gorab对于高尔基体复合物的囊泡转运很重要,以及在通过该隔室转移的货物蛋白上正确加工糖链。因此,我们认为GO是由构成皮肤和骨骼的蛋白质有缺陷引起的,从而导致在这些组织中观察到的病理作用。此处描述的工作旨在确定Gorab在高尔基体囊泡转运中的精确功能,然后确定gorab丢失如何影响分泌蛋白的修饰,重点关注那些构成皮肤的蛋白质。这项工作不仅对于确定GO机制很重要,而且对于我们对货物修饰的理解具有更广泛的意义,这对所有细胞至关重要。此外,结果将告知我们皮肤的组装方式,以及皮肤在疾病中的变化以及在正常衰老过程中的可能性。最后,这项工作还与我们对组织再生和伤口修复等过程的理解有关。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Golgin Family of Coiled-Coil Tethering Proteins.
Vimentin intermediate filaments provide structural stability to the mammalian Golgi complex.
  • DOI:
    10.1242/jcs.260577
  • 发表时间:
    2023-10-15
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Vitali, Teresa;Sanchez-Alvarez, Rosa;Witkos, Tomasz M.;Bantounas, Ioannis;Cutiongco, Marie F. A.;Dudek, Michal;Yan, Guanhua;Mironov, Alexander A.;Swift, Joe;Lowe, Martin
  • 通讯作者:
    Lowe, Martin
A common pathomechanism in GMAP-210- and LBR-related diseases.
GMAP-210 和 LBR 相关疾病的常见病理机制。
  • DOI:
    10.1172/jci.insight.121150
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Wehrle A
  • 通讯作者:
    Wehrle A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin Lowe其他文献

Glutamate Release from Guinea‐Pig Synaptosomes: Stimulation by Reuptake‐Induced Depolarization
豚鼠突触体中谷氨酸的释放:再摄取诱导的去极化的刺激
  • DOI:
    10.1111/j.1471-4159.1989.tb07296.x
  • 发表时间:
    1989
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    H. McMahon;A. Barrie;Martin Lowe;D. Nicholls
  • 通讯作者:
    D. Nicholls
High prevalence of early repolarization in the pediatric relatives of Sudden Arrhythmic Death Syndrome (SADS) victims and in normal controls
心律失常性死亡综合症 (SADS) 患者的儿科亲属和正常对照中早期复极的发生率较高
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. McCorquodale;R. Poulton;J. Hendry;G. Norrish;E. Field;Sarah;Mead;Martin Lowe;J. Kaski
  • 通讯作者:
    J. Kaski
Membrane transport: Tethers and TRAPPs
膜运输:系链和 TRAPP
  • DOI:
    10.1016/s0960-9822(00)00505-4
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    9.2
  • 作者:
    Martin Lowe
  • 通讯作者:
    Martin Lowe
Novel repolarisation metric predicts arrhythmia origin and clinical events in ARVC and Brugada Syndrome
新型复极指标可预测 ARVC 和 Brugada 综合征的心律失常起源和临床事件
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    C. Martin;M. Orini;N. Srinivasan;J. Bhar;S. Honarbakhsh;A. Chow;Martin Lowe;Ron D.B. Simon;Perry M. Elliott;P. Taggart;P. Lambiase
  • 通讯作者:
    P. Lambiase
Sinus node modification utilising a novel multi electrode catheter with orthogonal wavefront mapping
  • DOI:
    10.1016/j.ipej.2018.07.005
  • 发表时间:
    2018-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jonathan M. Behar;Emily Keating;Martin Lowe
  • 通讯作者:
    Martin Lowe

Martin Lowe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martin Lowe', 18)}}的其他基金

Understanding and treating neurogenetic conditions related to the Kennedy pathway
了解和治疗与肯尼迪通路相关的神经遗传疾病
  • 批准号:
    MR/Y014251/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
Determining the specificity of vesicle traffic at the Golgi apparatus
确定高尔基体囊泡运输的特异性
  • 批准号:
    BB/X006859/1
  • 财政年份:
    2023
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
Coordination of membrane traffic in the early secretory pathway
早期分泌途径中膜运输的协调
  • 批准号:
    BB/S014799/1
  • 财政年份:
    2019
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
A new role for intermediate filaments in the secretory pathway
中间丝在分泌途径中的新作用
  • 批准号:
    BB/T000945/1
  • 财政年份:
    2019
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
Mechanisms of endocytic recycling in the renal proximal tubule
肾近曲小管内吞再循环机制
  • 批准号:
    BB/N000641/1
  • 财政年份:
    2016
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
The role of OCRL1 in endocytic membrane traffic
OCRL1在内吞膜运输中的作用
  • 批准号:
    MR/K000810/1
  • 财政年份:
    2013
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
Dissecting the roles of ZFPL1 and GMAP210 in Golgi biogenesis and membrane traffic
剖析 ZFPL1 和 GMAP210 在高尔基体生物发生和膜运输中的作用
  • 批准号:
    BB/I007717/1
  • 财政年份:
    2011
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
A Manchester-Beijing Strategic Parntership in Molecular Life Sciences
曼彻斯特-北京分子生命科学战略合作伙伴关系
  • 批准号:
    BB/H531600/1
  • 财政年份:
    2010
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
Mitotic regulation of the Golgi apparatus- the role of the ARF nucleotide exchange factor GBF1
高尔基体的有丝分裂调节——ARF核苷酸交换因子GBF1的作用
  • 批准号:
    BB/F005628/1
  • 财政年份:
    2008
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant
Molecular organisation of the secretory and endocytic pathways
分泌和内吞途径的分子组织
  • 批准号:
    G0501725/1
  • 财政年份:
    2006
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Research Grant

相似国自然基金

脂肪组织新型内分泌因子的鉴定及功能研究
  • 批准号:
    82330023
  • 批准年份:
    2023
  • 资助金额:
    220 万元
  • 项目类别:
    重点项目
生姜6-姜酚调控IDO1信号通路改善肠道粘液屏障功能的机制探究
  • 批准号:
    32301974
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
mRNA反式调控基因转录的机制及其生物学功能
  • 批准号:
    32330018
  • 批准年份:
    2023
  • 资助金额:
    220 万元
  • 项目类别:
    重点项目
轻量化多功能因瓦合金多孔材料增材制造与性能表征评价
  • 批准号:
    12372133
  • 批准年份:
    2023
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目
钛合金表面微区电势差特征促细胞功能表达及其免疫微环境作用机制
  • 批准号:
    32371390
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Doctoral Dissertation Research: Assessing the chewing function of the hyoid bone and the suprahyoid muscles in primates
博士论文研究:评估灵长类动物舌骨和舌骨上肌的咀嚼功能
  • 批准号:
    2337428
  • 财政年份:
    2024
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Standard Grant
CAREER: Many-Body Green's Function Framework for Materials Spectroscopy
职业:材料光谱的多体格林函数框架
  • 批准号:
    2337991
  • 财政年份:
    2024
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Standard Grant
Testing Theorems in Analytic Function Theory, Harmonic Analysis and Operator Theory
解析函数论、调和分析和算子理论中的检验定理
  • 批准号:
    2349868
  • 财政年份:
    2024
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Standard Grant
CAREER: Microbial control of intestinal organoids development and function
职业:肠道类器官发育和功能的微生物控制
  • 批准号:
    2240045
  • 财政年份:
    2024
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Continuing Grant
肝癌薬物療法における奏功性に関わるケモカインの同定と治療標的としての可能性
鉴定与肝癌药物治疗有效性相关的趋化因子及其作为治疗靶点的潜力
  • 批准号:
    24K11106
  • 财政年份:
    2024
  • 资助金额:
    $ 51.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了